TKITalk an on-demand, self-paced, Section 3 accredited educational program addressing different topics related to the disease state and treatment of renal cell carcinoma (RCC), differentiated thyroid cancer (DTC), hepatocellular carcinoma (HCC), neuroendocrine tumours (NET), and overall safety considerations for tyrosine kinase inhibitors.

This program is aimed to expand the knowledge and skills of Canadian oncologists and to encourage reflection on current practice and ways to improve the management and outcomes of patients on TKIs. Expert Canadian faculty members share their expertise in 8 short videos addressing key questions seen in practice. You have an opportunity to gain credits per topic of interest and reflect on your current practices while identifying ways to apply your learnings to enhance patient outcomes.

FR

Let’s see if you’ve been here before. A magic link will be emailed to you to access the site. If you’re new, you’ll have the opportunity to register.

Intended for Healthcare Professionals Only | Contact | Terms of Use | Privacy Notice

This activity is an accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada and approved by the Queen's University CPD Team. You may claim a maximum of 2 hours (credits are automatically calculated).